Abridge vs Suki (2026)
Both integrate deeply with Epic and part ways after that. Abridge concentrates on the note and the trust around it, with Best in KLAS for Ambient AI in 2025 and 2026, a Kaiser Permanente evaluation published in NEJM AI, and Linked Evidence tracing every sentence of a note back to the source audio. Suki is a voice assistant in which the scribe is half the product: commands order medications, navigate charts, query the patient record and stage orders for review, across bidirectional integrations with Epic, Oracle Health, athenahealth, MEDITECH and Elation, and Suki Platform lets other vendors embed it. If your failure mode is note quality and evidence a committee will accept, start with Abridge. If it is everything around the note, the ordering, navigating and querying that eat the visit, start with Suki. Neither publishes a price.
- Kaiser Permanente's evaluation of Abridge is published as peer reviewed research in NEJM AI, and Abridge was named Best in KLAS for Ambient AI in 2025 and 2026, where Suki's published figures carry no study design or sample.
- Linked Evidence maps every part of a generated note back to the source audio, so a clinician can check any sentence against what was said before signing.
- The Epic work goes past the note, with native embedding across Haiku, Canto and Hyperdrive, structured orders and real time prior authorization.
- Voice operates the EHR. Commands order medications, navigate charts, query the specific patient record, stage orders for review and pull schedules.
- Record system reach is broad, with bidirectional integrations with Epic, Oracle Health, athenahealth, MEDITECH and Elation and a partner program reaching MEDENT, Azalea Health and WellSky.
- Retention is stated, with audio and transcripts deleted after 30 days by default, and Suki Platform lets other healthcare software vendors embed its voice and ambient capabilities.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Abridge and Suki are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Abridge | Suki |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | 2018 | 2017 |
| Headquarters | Pittsburgh, Pennsylvania | Redwood City, California |
| Website | abridge.com | suki.ai |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Abridge is an enterprise ambient AI platform that turns the clinician patient conversation into a structured, billable note inside the EHR, sold to health systems rather than to individual clinicians. It partners with more than 300 health systems, including Kaiser Permanente, Mayo Clinic, Johns Hopkins, Duke Health, Memorial Sloan Kettering, Northwell, UPMC, Sutter Health and NYU Langone, and won the KLAS Research award for Ambient AI in 2025 and 2026.
Source: AI Health Index, July 2026
Suki pairs ambient documentation with a voice command layer over the EHR. Clinicians can dictate, capture visits ambiently, or use voice commands to order medications, navigate charts, query patient records, stage orders for review and pull schedules. The product also offers ICD-10, E/M and HCC coding assistance, chart aware clinical questions answered against the patient record, and pre visit summaries.
Source: AI Health Index, July 2026
Questions buyers ask
How do Abridge and Suki work with the EHR?
For Abridge, the integration is embedded in Epic Haiku and Hyperdrive, so recording, review and the finished note stay in the Epic workflow with no copy and paste step and no parallel interface. The February 2024 Epic announcement described the path as running from recording conversations in Haiku to embedding generated notes in the patient chart in Hyperdrive.
A clinician speaks the recommended orders, and Suki structures, codes and stages them in the EHR for review and sign off. At launch, Suki named labs, imaging, referrals and other order types across Epic, Cerner and MEDITECH as the next step. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
How do Abridge and Suki handle patient data?
In Abridge's case, the OpenAI listing indicates that content derived from the encounter reaches a third party model provider.
Suki does not identify the clinician or the patient in voice recordings, creates and keeps no voice signatures, and uses voice only to transcribe and summarize the note. Audio and transcripts are permanently deleted after 30 days, and the final clinical note is kept for the length of the service contract. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
Which settings and specialties do Abridge and Suki cover?
The clinicians platform page says Abridge is used at over 40 specialties, with a structured, specialty specific note produced for each visit.
In Suki's case, the homepage claims use across more than 100 specialties, on desktop and on iOS and Android devices, in various care settings. Integration with Epic, Oracle Health, athenahealth and MEDITECH puts the product inside the EHRs most US health systems run, from large integrated networks down to ambulatory practices. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
What evidence is published for Abridge and Suki?
In the findings Abridge highlights, 1,306 users left 8,986 star ratings, 1,252 self reviews and 3,600 free text comments, and optimized PDQI self reviews averaged 4.35 out of 5. Abridge supported more than 4 million patient encounters as of November 2024.
With Suki, deployment scale carries most of the public case. MedStar Health expanded its partnership and put the product in front of thousands of clinicians across ambulatory specialties, alongside partnerships with Zoom and athenahealth. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified July 22, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
Deployment and outcome figures for both vendors are vendor published, including Abridge's more than 300 health systems and Suki's homepage claims, which carry no study design. Suki stages orders for clinician review rather than submitting them, but publishes no accuracy figure for command interpretation, and a misread medication order carries more consequence than a flawed sentence. Neither vendor publishes a price.
An earlier version of this comparison said Suki does not address model training in its published materials; Suki states that anything it uses for model training is de identified. That statement was corrected on 10 October 2026.